Treace Medical Concepts, Inc. (TMCI) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Treace Medical Concepts, Inc. (TMCI:NASDAQ), powered by AI.

Current Price
$4.12
Sector
Healthcare
What is the Treace Medical Concepts, Inc. stock price forecast?

Treace Medical Concepts, Inc. is currently trading at $4.12. View real-time AI analysis on Alpha Lenz.

What is Treace Medical Concepts, Inc. insider trading activity?

View the latest insider trading data for Treace Medical Concepts, Inc. on Alpha Lenz.

What is Treace Medical Concepts, Inc.'s P/E ratio?

View Treace Medical Concepts, Inc.'s valuation metrics on Alpha Lenz.

Treace Medical Concepts, Inc.

NASDAQ · TMCI
$4.12+0.20(+5.10%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Treace Medical Concepts, Inc.'s future dividend policy...
Alpha Chat Insight

Treace Medical Concepts, Inc.'s ROE is -58.9%. Explore profitability and growth together.

Ask for details

Company Overview

Treace Medical Concepts Inc. specializes in medical device development, focusing primarily on orthopedic solutions. Its flagship product is the Lapiplasty 3D Bunion Correction System, designed to address common deformities associated with bunions. This innovative system allows for precise correction in three dimensions, providing a unique, cutting-edge solution in the podiatric surgery field. Targeting hospitals, surgeons, and healthcare providers, Treace Medical Concepts plays a significant role in the medical sector by offering improved patient outcomes and recovery experiences. Headquartered in Ponte Vedra, Florida, the company supports its distribution through a strong network of sales representatives and medical partnerships in the United States. By integrating research and technology into its product design, Treace Medical Concepts Inc. contributes to advancements in surgical techniques, positioning itself as a pivotal player within the healthcare and medical device industry.

CEOMr. John T. Treace
SectorHealthcare
IndustryMedical Devices
Employees477

Company Statistics

FY 2025

Profile

N/AMarket Cap
$212.69MRevenue
0.00Shares Out
477Employees

Margins

79.81%Gross
-18.96%EBITDA
-25.46%Operating
-27.74%Pre-Tax
-27.74%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

14.46%Rev 3Yr
29.96%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-28.95%ROA
-58.94%ROE
-26.34%ROIC

Financial Health

$10.71MCash & Cash Equivalents
$92.54MNet Debt
118.23%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Treace Medical Concepts, Inc. (ticker: TMCI) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 477 employees.

The current price is $4.12 with a P/E ratio of -x and P/B of -x.

ROE is -58.94% and operating margin is -25.46%. Annual revenue is $213M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Treace Medical Concepts, Inc. (TMCI) Stock Forecast 2026 $4.12 — Price, Financials & Analyst Targets | Alpha Lenz